1216.11.007 Boehringer Ingelheim Investigational Site
Fayetteville, Arkansas
0 studies enrolling now ยท 1 studies all time
What they study most
Carcinoma, Small Cell
Studies at this site
- BI 2536 Second Line Monotherapy in SCLC โ Completed
Fayetteville, Arkansas
0 studies enrolling now ยท 1 studies all time
Carcinoma, Small Cell